Company
Disc Medicine, Inc. (IRON)
Standardized SEC financial data for Disc Medicine, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001816736 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-28.7%
Free cash flow
-$181.3M
Debt / equity
0.04×
Current ratio
21.94×
EPS (diluted)
$-6.01
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $28.2M | $25.2M | $33.4M | $69.3M | $96.7M | $170.6M |
| SG&A expense |
Balance sheet
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $88.2M | $194.8M | $360.6M | $489.9M | $791.2M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$32.7M | -$27.5M | -$42.3M | -$73.5M | -$93.9M | -$180.4M |
| Capital expenditures |
Get IRON data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/IRON/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/IRON/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"